USA Hepatitis A Vaccine Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

    Two types of HAV vaccines are currently available internationally:1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.The classification of Hepatitis A Vaccine includes Inactivated Vaccine, Live Attenuated Vaccine, and the sales proportion of Inactivated Vaccine in 2017 is about 70.8%, and the proportion is increasing trend from 2013 to 2018.Inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Hepatitis A Vaccine market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Hepatitis A Vaccine market. Detailed analysis of key players, along with key growth strategies adopted by Hepatitis A Vaccine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • IMBCA

    • Sanofi

    • Sinovac

    • Merck

    • ChangSheng

    • Zhejiang Pukang

    • Kaketsuken

    • Convac

    • GSK

    • Changchun Institute of Biological

    By Type:

    • Inactivated Vaccine

    • Live Attenuated Vaccine

    By End-User:

    • Government Institution

    • Private Sector

    • Other

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Hepatitis A Vaccine Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Hepatitis A Vaccine Market Size and Growth Rate of Inactivated Vaccine from 2016 to 2027

      • 1.3.2 USA Hepatitis A Vaccine Market Size and Growth Rate of Live Attenuated Vaccine from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Hepatitis A Vaccine Market Size and Growth Rate of Government Institution from 2016 to 2027

      • 1.4.2 USA Hepatitis A Vaccine Market Size and Growth Rate of Private Sector from 2016 to 2027

      • 1.4.3 USA Hepatitis A Vaccine Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Hepatitis A Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Hepatitis A Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Hepatitis A Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Hepatitis A Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Hepatitis A Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Hepatitis A Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of Inactivated Vaccine

      • 3.4.2 Market Size and Growth Rate of Live Attenuated Vaccine

    4 Segmentation of Hepatitis A Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Hepatitis A Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Hepatitis A Vaccine in Government Institution

      • 4.4.2 Market Size and Growth Rate of Hepatitis A Vaccine in Private Sector

      • 4.4.3 Market Size and Growth Rate of Hepatitis A Vaccine in Other

    5 Market Analysis by Regions

    • 5.1 USA Hepatitis A Vaccine Production Analysis by Regions

    • 5.2 USA Hepatitis A Vaccine Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Hepatitis A Vaccine Landscape Analysis

    • 6.1 West USA Hepatitis A Vaccine Landscape Analysis by Major Types

    • 6.2 West USA Hepatitis A Vaccine Landscape Analysis by Major End-Users

    7 South USA Hepatitis A Vaccine Landscape Analysis

    • 7.1 South USA Hepatitis A Vaccine Landscape Analysis by Major Types

    • 7.2 South USA Hepatitis A Vaccine Landscape Analysis by Major End-Users

    8 Middle West USA Hepatitis A Vaccine Landscape Analysis

    • 8.1 Middle West USA Hepatitis A Vaccine Landscape Analysis by Major Types

    • 8.2 Middle West USA Hepatitis A Vaccine Landscape Analysis by Major End-Users

    9 Northeast USA Hepatitis A Vaccine Landscape Analysis

    • 9.1 Northeast USA Hepatitis A Vaccine Landscape Analysis by Major Types

    • 9.2 Northeast USA Hepatitis A Vaccine Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 IMBCA

        • 10.1.1 IMBCA Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Sanofi

        • 10.2.1 Sanofi Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Sinovac

        • 10.3.1 Sinovac Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Merck

        • 10.4.1 Merck Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 ChangSheng

        • 10.5.1 ChangSheng Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Zhejiang Pukang

        • 10.6.1 Zhejiang Pukang Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Kaketsuken

        • 10.7.1 Kaketsuken Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Convac

        • 10.8.1 Convac Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 GSK

        • 10.9.1 GSK Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Changchun Institute of Biological

        • 10.10.1 Changchun Institute of Biological Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Hepatitis A Vaccine Market Size and Growth Rate of Inactivated Vaccine from 2016 to 2027

    • Figure USA Hepatitis A Vaccine Market Size and Growth Rate of Live Attenuated Vaccine from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Hepatitis A Vaccine Market Size and Growth Rate of Government Institution from 2016 to 2027

    • Figure USA Hepatitis A Vaccine Market Size and Growth Rate of Private Sector from 2016 to 2027

    • Figure USA Hepatitis A Vaccine Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Hepatitis A Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Hepatitis A Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Hepatitis A Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Hepatitis A Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Hepatitis A Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Hepatitis A Vaccine

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Hepatitis A Vaccine by Different Types from 2016 to 2027

    • Table Consumption Share of Hepatitis A Vaccine by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Inactivated Vaccine

    • Figure Market Size and Growth Rate of Live Attenuated Vaccine

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Hepatitis A Vaccine by Different End-Users from 2016 to 2027

    • Table Consumption Share of Hepatitis A Vaccine by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Government Institution

    • Figure Market Size and Growth Rate of Private Sector

    • Figure Market Size and Growth Rate of Other

    • Table USA Hepatitis A Vaccine Production by Regions

    • Table USA Hepatitis A Vaccine Production Share by Regions

    • Figure USA Hepatitis A Vaccine Production Share by Regions in 2016

    • Figure USA Hepatitis A Vaccine Production Share by Regions in 2021

    • Figure USA Hepatitis A Vaccine Production Share by Regions in 2027

    • Table USA Hepatitis A Vaccine Consumption by Regions

    • Table USA Hepatitis A Vaccine Consumption Share by Regions

    • Figure USA Hepatitis A Vaccine Consumption Share by Regions in 2016

    • Figure USA Hepatitis A Vaccine Consumption Share by Regions in 2021

    • Figure USA Hepatitis A Vaccine Consumption Share by Regions in 2027

    • Table West USA Hepatitis A Vaccine Consumption by Types from 2016 to 2027

    • Table West USA Hepatitis A Vaccine Consumption Share by Types from 2016 to 2027

    • Figure West USA Hepatitis A Vaccine Consumption Share by Types in 2016

    • Figure West USA Hepatitis A Vaccine Consumption Share by Types in 2021

    • Figure West USA Hepatitis A Vaccine Consumption Share by Types in 2027

    • Table West USA Hepatitis A Vaccine Consumption by End-Users from 2016 to 2027

    • Table West USA Hepatitis A Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Hepatitis A Vaccine Consumption Share by End-Users in 2016

    • Figure West USA Hepatitis A Vaccine Consumption Share by End-Users in 2021

    • Figure West USA Hepatitis A Vaccine Consumption Share by End-Users in 2027

    • Table South USA Hepatitis A Vaccine Consumption by Types from 2016 to 2027

    • Table South USA Hepatitis A Vaccine Consumption Share by Types from 2016 to 2027

    • Figure South USA Hepatitis A Vaccine Consumption Share by Types in 2016

    • Figure South USA Hepatitis A Vaccine Consumption Share by Types in 2021

    • Figure South USA Hepatitis A Vaccine Consumption Share by Types in 2027

    • Table South USA Hepatitis A Vaccine Consumption by End-Users from 2016 to 2027

    • Table South USA Hepatitis A Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Hepatitis A Vaccine Consumption Share by End-Users in 2016

    • Figure South USA Hepatitis A Vaccine Consumption Share by End-Users in 2021

    • Figure South USA Hepatitis A Vaccine Consumption Share by End-Users in 2027

    • Table Middle West USA Hepatitis A Vaccine Consumption by Types from 2016 to 2027

    • Table Middle West USA Hepatitis A Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Hepatitis A Vaccine Consumption Share by Types in 2016

    • Figure Middle West USA Hepatitis A Vaccine Consumption Share by Types in 2021

    • Figure Middle West USA Hepatitis A Vaccine Consumption Share by Types in 2027

    • Table Middle West USA Hepatitis A Vaccine Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Hepatitis A Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Hepatitis A Vaccine Consumption Share by End-Users in 2016

    • Figure Middle West USA Hepatitis A Vaccine Consumption Share by End-Users in 2021

    • Figure Middle West USA Hepatitis A Vaccine Consumption Share by End-Users in 2027

    • Table Northeast USA Hepatitis A Vaccine Consumption by Types from 2016 to 2027

    • Table Northeast USA Hepatitis A Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Hepatitis A Vaccine Consumption Share by Types in 2016

    • Figure Northeast USA Hepatitis A Vaccine Consumption Share by Types in 2021

    • Figure Northeast USA Hepatitis A Vaccine Consumption Share by Types in 2027

    • Table Northeast USA Hepatitis A Vaccine Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Hepatitis A Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Hepatitis A Vaccine Consumption Share by End-Users in 2016

    • Figure Northeast USA Hepatitis A Vaccine Consumption Share by End-Users in 2021

    • Figure Northeast USA Hepatitis A Vaccine Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of IMBCA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IMBCA

    • Figure Sales and Growth Rate Analysis of IMBCA

    • Figure Revenue and Market Share Analysis of IMBCA

    • Table Product and Service Introduction of IMBCA

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Sinovac

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sinovac

    • Figure Sales and Growth Rate Analysis of Sinovac

    • Figure Revenue and Market Share Analysis of Sinovac

    • Table Product and Service Introduction of Sinovac

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of ChangSheng

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ChangSheng

    • Figure Sales and Growth Rate Analysis of ChangSheng

    • Figure Revenue and Market Share Analysis of ChangSheng

    • Table Product and Service Introduction of ChangSheng

    • Table Company Profile and Development Status of Zhejiang Pukang

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zhejiang Pukang

    • Figure Sales and Growth Rate Analysis of Zhejiang Pukang

    • Figure Revenue and Market Share Analysis of Zhejiang Pukang

    • Table Product and Service Introduction of Zhejiang Pukang

    • Table Company Profile and Development Status of Kaketsuken

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kaketsuken

    • Figure Sales and Growth Rate Analysis of Kaketsuken

    • Figure Revenue and Market Share Analysis of Kaketsuken

    • Table Product and Service Introduction of Kaketsuken

    • Table Company Profile and Development Status of Convac

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Convac

    • Figure Sales and Growth Rate Analysis of Convac

    • Figure Revenue and Market Share Analysis of Convac

    • Table Product and Service Introduction of Convac

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Changchun Institute of Biological

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Changchun Institute of Biological

    • Figure Sales and Growth Rate Analysis of Changchun Institute of Biological

    • Figure Revenue and Market Share Analysis of Changchun Institute of Biological

    • Table Product and Service Introduction of Changchun Institute of Biological


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.